Trials / Completed
CompletedNCT01498250
Microarray Analysis of microRNA Expression in Basal Cell Carcinoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 7 (actual)
- Sponsor
- Ruhr University of Bochum · Academic / Other
- Sex
- All
- Age
- 1 Year
- Healthy volunteers
- Not accepted
Summary
Perturbations in microRNA (miRNA) expression profiles has been reported for a variety of cancers. This study will be an exploratory analysis of miRNA expression in basal cell carcinoma by miRNA expression profiling using microarrays.
Detailed description
Perturbations in the expression profiles of microRNAs (miRNAs) have been reported for a variety of different cancers. Basal cell carcinoma (BCC) of the skin has not been systematically evaluated regarding differentially expressed miRNAs. Patients with BCC are included in the study to perform an exploratory analysis by miRNA expression profiling using microarrays. Expression levels of miRNA candidates will be validated by TaqMan real-time quantitative polymerase chain reaction (RT-PCR).
Conditions
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2011-12-23
- Last updated
- 2012-10-16
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01498250. Inclusion in this directory is not an endorsement.